Abstract
Acromegaly is a progressive disease caused by an increased in the levels of growth hormone (GH), followed by an increased in the levels of insulin-like growth factor-1 (IGF-1). Most cases are caused by GH-secreting pituitary adenomas. Long-term exposure to excessive GH would affect all systems of the body, of which the cardiovascular system has the highest incidence rate and mortality rate. This review discusses the influence of acromegaly on cardiovascular diseases and its treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
